Changes to cost recovery arrangements from 1 July 2021

Page last updated: 25 June 2021

The 2021-22 Pharmaceutical Benefits Scheme (PBS) and National Immunisation Plan (NIP) Cost Recovery Implementation Statement (CRIS) is now available on the PBS Cost Recovery Fees and Charges webpage. The CRIS provides information for industry on how the Department administers cost recovery arrangements and sets out the fees will apply to PBS/NIP applications for the 2021-22 financial year.

New fees will apply to all PBS/NIP listings from 1 July 2021.

The PBS Cost Recovery Fees and Charges webpage has been updated for the 2021-22 financial year including:

• Updates to the fee table for 1 July 2021.
• Publication of the 2021-22 CRIS.
• Link to the National Health (Pharmaceuticals and Vaccines – Cost Recovery) Amendment (Fees) Regulations 2021.
• Link to the Explanatory Statement for the National Health (Pharmaceuticals and Vaccines – Cost Recovery) Amendment (Fees) Regulations 2021.

Background

The Department conducted an annual review of PBS/NIP listing and management fees to come into effect on 1 July 2021.

The activity based costing model previously agreed by Government remains the basis for charging categories and rates.

An indexation approach has been applied to all fees to reflect the current efficient costs of delivering services based on an inflation rate for future years set by the Department of Finance.

Public consultation on the draft 2021-22 CRIS was undertaken In April 2021. The published CRIS incorporates stakeholder feedback.

If you have any questions regarding these updates please email PBScostrecovery@health.gov.au